경구 단백질 및 펩타이드 시장 규모, 점유율, 성장 분석 : 투여 경로별, 분자 유형별, 용도별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Oral Proteins And Peptides Market size was valued at USD 1.19 Billion in 2024 and is poised to grow from USD 1.32 Billion in 2025 to USD 82.87 Billion by 2033, growing at a CAGR of 11.3% during the forecast period (2026-2033).

The Global Oral Proteins and Peptides Market encompasses the formulation, manufacturing, and distribution of protein-based therapeutics and peptides designed for oral administration, providing alternatives to injectable biologics and enhancing access to treatments for chronic diseases and nutritional needs. Market growth, initially hindered by low bioavailability challenges, has been revitalized through innovations in encapsulation techniques, enabling peptides, like GLP-1 analogues, to withstand gastric degradation. This evolution has propelled market value significantly, driven by increasing diabetes prevalence and an aging demographic seeking oral therapies. The integration of advanced delivery platforms with peptide drugs improves therapeutic exposure akin to injections, reducing costs and boosting patient adherence. Additionally, strategic collaborations are enhancing peptide stability, unlocking new therapies for a range of chronic conditions, thereby accelerating market expansion. AI-driven automation further enhances product development efficiency by optimizing formulation design and streamlining quality control processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oral Proteins And Peptides market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oral Proteins And Peptides Market Segments Analysis

Global oral proteins and peptides market is segmented by route of administration, molecule type, application, distribution channel, end user and region. Based on route of administration, the market is segmented into Oral Tablets, Oral Capsules, Oral Solutions & Suspensions and Others. Based on molecule type, the market is segmented into Proteins and Peptides. Based on application, the market is segmented into Diabetes, Gastrointestinal Disorders, Hormonal Disorders, Metabolic Disorders, Infectious Diseases and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oral Proteins And Peptides Market

The rising demand for orally administered therapeutics significantly propels the growth of the global oral proteins and peptides market. Patients and healthcare providers increasingly favor convenient, non-injection options that enhance adherence while minimizing the need for clinical visits. This shift motivates pharmaceutical companies to focus on developing stable formulations of proteins and peptides that are suitable for oral consumption, leading to advancements in protective coatings, absorption enhancers, and innovative excipients. As a result, an expanding product pipeline and a surge in clinical trials for orally delivered biologics strengthen market demand, creating a dynamic cycle of research, development, and increased adoption within the global pharmaceutical sector.

Restraints in the Global Oral Proteins And Peptides Market

The Global Oral Proteins and Peptides market faces significant challenges due to stringent regulatory requirements that emphasize safety, efficacy, and quality standards. These frameworks often lengthen development timelines and introduce uncertainty for companies. Regulatory agencies commonly demand extensive data regarding gastrointestinal stability, absorption processes, and long-term safety, leading to the need for additional preclinical and clinical trials. This rigorous oversight not only elevates costs but also discourages smaller firms from participating in the market, thereby restricting competitive dynamics. As a consequence, the introduction of new products slows down, limiting overall market expansion, while investors tend to favor projects with more straightforward regulatory approvals, reducing the diversity of the development pipeline.

Market Trends of the Global Oral Proteins And Peptides Market

The Global Oral Proteins and Peptides market is experiencing a significant shift driven by consumer demand for personalized healthcare solutions. Manufacturers are increasingly focused on developing peptide-based oral formulations that specifically address various gastrointestinal and systemic health issues. By harnessing advancements in peptide stability, encapsulation, and targeted release technologies, companies are creating tailored products that cater to individual genetic profiles and lifestyle choices. This trend towards personalization not only enhances therapeutic efficacy and minimizes adverse effects but also fosters brand loyalty. Firms that prioritize investment in precision oral peptides are establishing themselves as key players in the evolving market landscape of global healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Oral Proteins and Peptides Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral Tablets
• Oral Capsules
• Oral Solutions & Suspensions
• Others

Global Oral Proteins and Peptides Market Size by Molecule Type & CAGR (2026-2033)

• Market Overview
• Proteins
• Peptides

Global Oral Proteins and Peptides Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diabetes
• Gastrointestinal Disorders
• Hormonal Disorders
• Metabolic Disorders
• Infectious Diseases
• Others

Global Oral Proteins and Peptides Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Oral Proteins and Peptides Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Home Care Settings

Global Oral Proteins and Peptides Market Size & CAGR (2026-2033)

• North America (Route of Administration, Molecule Type, Application, Distribution Channel, End User)
  • US
  • Canada
• Europe (Route of Administration, Molecule Type, Application, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Route of Administration, Molecule Type, Application, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Route of Administration, Molecule Type, Application, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Route of Administration, Molecule Type, Application, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk A S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chiasma Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myrcludex GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oramed Pharmaceuticals Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rani Therapeutics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enteris BioPharma Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emisphere Technologies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synergy Pharmaceuticals Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proxima
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations